News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InnoPharm Ltd. Announces Commercial Launch of Acamprosate Delayed-Release Tablets in the United States


8/15/2013 9:51:02 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PISCATAWAY, NJ, Aug. 15, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc. today announced the launch of acamprosate calcium, 333 mg delayed-release tablets (generic equivalent of CampralĀ®). InnoPharma developed the generic formulation of acamprosate delayed-release tablets and entered into an agreement with Glenmark Pharmaceuticals, Inc. pursuant to which Glenmark will sell, market and distribute acamprosate in the United States.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES